GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 2776 - 2800 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▲ Arbitrary Fluorescence Units (AFU)
IgA Patient 2 3 mild
G66937TJ
500
IgG Patient 2 3 mild
G66937TJ
57
IgM Patient 2 3 mild
G66937TJ
334
IgA Patient 3 -180 mild
G66937TJ
293
IgA Patient 3 11 mild
G66937TJ
426
IgG Patient 3 -180 mild
G66937TJ
48
IgM Patient 3 -180 mild
G66937TJ
134
IgA Patient 3 4 mild
G66937TJ
456
IgG Patient 3 11 mild
G66937TJ
57
IgG Patient 3 4 mild
G66937TJ
50
IgM Patient 3 11 mild
G66937TJ
246
IgM Patient 3 4 mild
G66937TJ
218
IgA Patient 4 12 mild
G66937TJ
396
IgG Patient 4 12 mild
G66937TJ
85
IgM Patient 4 12 mild
G66937TJ
252
IgA Patient 1 10 moderate
G67045LB
420
IgA Patient 1 22 moderate
G67045LB
386
IgA Patient 1 6 moderate
G67045LB
389
IgG Patient 1 10 moderate
G67045LB
27
IgG Patient 1 22 moderate
G67045LB
34
IgM Patient 1 10 moderate
G67045LB
65
IgM Patient 1 22 moderate
G67045LB
181
IgG Patient 1 6 moderate
G67045LB
29
IgM Patient 1 6 moderate
G67045LB
75
IgA Patient 2 15 mild
G67045LB
341

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024